Meet Our Team of Expert Doctors
Dr. P. Raghu Ram
MBBS, MD (Oncology), Fellowship in Molecular Diagnostics
Dr. P. Raghu Ram is a leading oncologist with over a decade of expertise in cancer diagnosis and research. As a core member of PreRNA’s medical advisory board, he has been instrumental in validating PreRNA’s microRNA-based technology for breast cancer detection. He specializes in precision diagnostics and personalized treatment approaches, ensuring patients benefit from the latest medical innovations. Dr. P. Raghu Ram is passionate about making advanced cancer screening accessible to women across India and regularly speaks at national conferences on early detection and molecular oncology.
Dr. Senthil J. Rajappa
MBBS, MS (Pathology), PhD in Molecular Biology
Dr.Senthil J Rajappa is an eminent molecular biologist and cancer researcher with extensive experience in developing and validating advanced diagnostic tools. At PreRNA, He leads the scientific validation team, ensuring every CANTEL test meets the highest standards of accuracy and reliability. His groundbreaking work in microRNA biomarker research has contributed significantly to CANTEL’s ability to detect breast cancer at any stage. He is committed to empowering women with safe, painless, and radiation-free screening options, bridging the gap between cutting-edge science and patient care.
Collaborators
Centre for Cellular and Molecular Biology (CCMB), Hyderabad
Regional Cancer Centre, Thiruvananthapuram (RCC)
Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad
Krishna Institute of Medical Sciences (KIMS), Hyderabad
What the Experts Say About Cantel
Dr. P. Raghu Ram
I congratulate Team CANTEL for developing an innovative microRNA-based blood test for breast cancer detection. This painless, radiation-free solution is suitable for women of all ages and can be done at home or in a Vijaya Diagnostics Centre. I believe CANTEL will make early detection easier, safer, and more accessible, helping improve outcomes in our fight against breast cancer.
Dr. Senthil J. Rajappa
Cantel’s blood-based screening is a significant advancement in breast cancer detection. By using cutting-edge microRNA technology, it identifies cancer at any stage without the discomfort or risks of traditional methods. This innovation empowers women to take charge of their health with a quick, safe, and accurate test.